Immunology & Autoimmune
Part of Biotech - Drug Development
| Ticker | Company | Mkt Cap▼ | Price | Chg% | Volume |
|---|---|---|---|---|---|
 JNJ | Johnson & Johnson | $0.6t | $242.28 | -0.3% | 785.8K |
 ABBV | ABBVIE INC. | $377.0b | $207.41 | -0.7% | 817.8K |
 AMGN | Amgen Inc | $188.1b | $344.51 | -1.0% | 574.6K |
 BMY | Bristol-Myers Squibb Co. | $122.0b | $59.05 | -0.9% | 1.2M |
 REGN | Regeneron Pharmaceuticals Inc | $79.2b | $763.78 | +0.3% | 95.7K |
 ROIV | Roivant Sciences Ltd. Common Shares | $18.9b | $28.17 | -0.6% | 1.1M |
 IBRX | ImmunityBio, Inc. Common Stock | $6.8b | $7.32 | +0.2% | 4.8M |
 PTGX | Protagonist Therapeutics, Inc | $6.4b | $102.41 | -1.3% | 71.5K |
 APGE | Apogee Therapeutics, Inc. Common Stock | $5.9b | $83.67 | -0.8% | 110.1K |
 TGTX | TG Therapeutics, Inc. | $5.0b | $35.03 | +4.5% | 489.3K |
 IMVT | Immunovant, Inc. Common Stock | $4.8b | $24.52 | +0.1% | 270.7K |
 DNTH | Dianthus Therapeutics, Inc. Common Stock | $4.2b | $86.66 | +0.8% | 450.4K |
 SYRE | Spyre Therapeutics, Inc. Common Stock | $3.6b | $47.95 | +0.8% | 116.0K |
 VERA | Vera Therapeutics, Inc. Class A Common Stock | $2.7b | $40.90 | +0.1% | 314.8K |
 ARQT | Arcutis Biotherapeutics, Inc. Common Stock | $2.6b | $23.84 | +0.9% | 217.6K |
 RCUS | Arcus Biosciences, Inc. | $2.6b | $22.94 | -0.1% | 130.8K |
 ALMS | Alumis Inc. Common Stock | $2.6b | $22.25 | -4.8% | 323.5K |
 ORKA | Oruka Therapeutics, Inc. Common Stock | $2.3b | $55.49 | +4.1% | 785.2K |
 APLS | Apellis Pharmaceuticals, Inc. Common Stock | $2.2b | $40.58 | +0.4% | 2.5M |
 ADMA | ADMA Biologics, Inc. | $2.2b | $9.38 | +2.1% | 822.3K |
 CLDX | Celldex Therapeutics, Inc | $2.0b | $31.38 | +1.0% | 291.5K |
 NKTR | Nektar Therapeutics | $1.9b | $75.37 | -2.1% | 72.0K |
 AUPH | Aurinia Pharmaceuticals Inc | $1.9b | $15.98 | +2.4% | 412.3K |
 ANAB | AnaptysBio, Inc. Common Stock | $1.6b | $62.64 | +8.6% | 146.6K |
 BHVN | Biohaven Ltd. | $1.2b | $9.47 | -3.3% | 250.1K |
 MLTX | MoonLake Immunotherapeutics Class A Ordinary Shares | $1.2b | $17.79 | +2.5% | 250.2K |
 CRVS | Corvus Pharmaceuticals, Inc. | $1.1b | $15.31 | +4.2% | 223.6K |
 DBVT | DBV Technologies S.A. | $1.1b | $20.62 | -2.1% | 31.4K |
 SEPN | Septerna, Inc. Common Stock | $1.0b | $25.18 | +0.0% | 36.1K |
 ZBIO | Zenas BioPharma, Inc. Common Stock | $1.0b | $22.35 | +4.1% | 233.9K |
 XNCR | Xencor, Inc. | $0.8b | $12.70 | -0.9% | 314.4K |
 CGEM | Cullinan Therapeutics, Inc. Common Stock | $0.8b | $15.22 | +5.5% | 505.0K |
 EVMN | Evommune, Inc. | $0.8b | $24.34 | +2.6% | 28.8K |
 ANNX | Annexon, Inc. Common Stock | $0.7b | $5.72 | +4.1% | 779.0K |
 JBIO | Jade Biosciences, Inc. Common Stock | $0.7b | $15.91 | +2.7% | 274.8K |
 ZURA | Zura Bio Limited Class A Ordinary Shares | $0.5b | $6.05 | +0.3% | 58.9K |
 UPB | Upstream Bio, Inc. Common Stock | $477.8m | $9.68 | +1.9% | 104.4K |
 RIGL | Rigel Pharmaceuticals Inc. (New) | $475.1m | $27.68 | +0.5% | 41.9K |
 KYTX | Kyverna Therapeutics, Inc. Common Stock | $458.3m | $9.20 | +3.7% | 193.7K |
 IMMX | Immix Biopharma, Inc. Common Stock | $454.4m | $9.12 | +2.0% | 96.9K |
 STTK | Shattuck Labs, Inc. Common Stock | $426.5m | $6.43 | +0.2% | 59.0K |
 ACRS | Aclaris Therapeutics, Inc. | $422.6m | $4.12 | -2.0% | 325.4K |
 IPSC | Century Therapeutics, Inc. Common Stock | $364.8m | $2.27 | +6.8% | 171.3K |
 ENTA | Enanta Pharmaceuticals, Inc | $353.5m | $13.51 | +2.8% | 21.6K |
 FBRX | Forte Biosciences, Inc. Common Stock | $329.7m | $26.43 | +3.3% | 24.9K |
 AVTX | Avalo Therapeutics, Inc. Common Stock | $317.4m | $17.70 | -0.3% | 539.0K |
 CLYM | Climb Bio, Inc. Common Stock | $312.4m | $6.95 | +5.9% | 85.6K |
 PALI | Palisade Bio, Inc. Common Stock | $295.6m | $2.00 | +5.6% | 1.4M |
 CABA | Cabaletta Bio, Inc. Common Stock | $275.0m | $3.12 | +5.2% | 1.3M |
 SABS | SAB Biotherapeutics, Inc. Common Stock | $265.6m | $3.87 | -0.4% | 47.3K |